Anticoagulation in Continuous Renal Replacement Therapy

27
ANTICOAGULATION IN CONTINUOUS RENAL REPLACEMENT THERAPY Dawn M Eding RN BSN CCRN Pediatric Critical Care Helen DeVos Children's Hospital

description

Anticoagulation in Continuous Renal Replacement Therapy. Dawn M Eding RN BSN CCRN Pediatric Critical Care Helen DeVos Children's Hospital. Goal of Anticoagulation Maintain patency of CRRT circuit. Minimize patient complications of anticoagulation therapies. Sites of Clot Formation - PowerPoint PPT Presentation

Transcript of Anticoagulation in Continuous Renal Replacement Therapy

Page 1: Anticoagulation in Continuous Renal Replacement Therapy

ANTICOAGULATION IN CONTINUOUS RENAL

REPLACEMENT THERAPY

Dawn M EdingRN BSN CCRN

Pediatric Critical CareHelen DeVos Children's Hospital

Page 2: Anticoagulation in Continuous Renal Replacement Therapy

Goal of Anticoagulation Maintain patency of CRRT circuit. Minimize patient complications of

anticoagulation therapies.

Page 3: Anticoagulation in Continuous Renal Replacement Therapy

Sites of Clot Formation Hemofilter Bubble trap, dearation chamber Catheter Leurlock and 3 way stopcock

connections

Page 4: Anticoagulation in Continuous Renal Replacement Therapy

Factors Influencing Circuit Clotting and

Filter Life Vascular access Blood flow Circuit alarms Anticoagulant

Page 5: Anticoagulation in Continuous Renal Replacement Therapy

Vascular access Site

Jugular Subclavian Femoral

Catheter size Catheter connections

Page 6: Anticoagulation in Continuous Renal Replacement Therapy

Vascular access needs to provide adequate flow to provide optimal therapy with minimal interruptions.

Page 7: Anticoagulation in Continuous Renal Replacement Therapy

Properly functioning access is the key to successful CRRT therapy.

Page 8: Anticoagulation in Continuous Renal Replacement Therapy

Blood Flow Ideal flow rates

3-5ml/kg/minute Access will ultimately determine

blood flow

Page 9: Anticoagulation in Continuous Renal Replacement Therapy

Circuit Alarms Ideal circuit pressures

Page 10: Anticoagulation in Continuous Renal Replacement Therapy

Anticoagulation Options Citrate Heparin Citrate and low dose heparin No anticoagulation

Page 11: Anticoagulation in Continuous Renal Replacement Therapy

Citrate Anticoagulation Regional anticoagulation of the CRRT

system Coagulation is a calcium dependent process Citrate acts by binding calcium Less risk of bleeding Commercially available solutions exist 

Page 12: Anticoagulation in Continuous Renal Replacement Therapy

Citrate Protocol Infused pre filter Start infusion at 1.5 times blood flow rate Requires monitoring of circuit and patient ionized

calcium levels Adjust infusion based on post filter ionized calcium

levels Aim for post-filter ionized calcium level between 0.25 and 0.4 mmols/L

Requires calcium free dialysate and replacement solutions

Page 13: Anticoagulation in Continuous Renal Replacement Therapy
Page 14: Anticoagulation in Continuous Renal Replacement Therapy
Page 15: Anticoagulation in Continuous Renal Replacement Therapy

Citrate Infusion Titration Scale 

Circuit Ionized Calcium

Citrate infusion adjustment

< .25 rate by 10 mL/hour

0.25 – 0.39 (optimum range)

No adjustment

0.4 – 0.5 rate by 10 mL/hour

> 0.5 rate by 20 mL/hour

Page 16: Anticoagulation in Continuous Renal Replacement Therapy

Potential Complication of Citrate: Hypocalcemia

Infusion of calcium chloride solution to patient via a central venous access is necessary to avoid hypocalcemia.

Solution consists of 8gm Calcium Chloride in 1L NS Start infusion at 40% of citrate flow rate Adjust calcium chloride infusion based on

patient ionized calcium levels Aim for patient ionized calcium level of 1.1

to 1.3 mmols/L

Page 17: Anticoagulation in Continuous Renal Replacement Therapy

Calcium Chloride Titration Scale

Patient ionized calcium (mmol/L)

Calcium Infusion Adjustment

> 1.3 rate by 10 mL/hour

1.1 – 1.3 (optimum range)

No adjustment

0.9 – 1.1 rate by 10 mL/hour

< .9 rate by 20 mL/hour

Page 18: Anticoagulation in Continuous Renal Replacement Therapy

Potential Complication of Citrate: Metabolic Alkalosis Related to rate of citrate metabolism in liver Citrate converts to HCO3 (1 mmol of citrate

converts to 3 mmols of HCO3) Correction of alkalosis can be done by

adjusting the bicarbonate concentration in replacement and dialysate solutions, decreasing the citrate rate, or by infusing 0.9% normal saline (pH 5.4) as a replacement or dialysate solution.

Page 19: Anticoagulation in Continuous Renal Replacement Therapy

Potential Complication of Citrate:Hyperglycemia ACDA solution contains 2.45gm/dl of

dextrose Adjustments in other dextrose sources (TPN etc.) and/or insulin infusions may become necessary.

Page 20: Anticoagulation in Continuous Renal Replacement Therapy

Potential Complication of Citrate: Citrate Lock Seen with rising patient total calcium

while patient’s ionized calcium is in normal range or dropping

Essentially the delivery of citrate exceeds the hepatic metabolism and CRRT clearance

Page 21: Anticoagulation in Continuous Renal Replacement Therapy

Treatment of Citrate Lock Decrease citrate rate Adjust scale of acceptable post filter

ionized calcium range Stop citrate infusion for 10-30 minutes

and restart at a lower rate Increase clearance by adjusting

Replacement and/or Dialysate flow rates

Page 22: Anticoagulation in Continuous Renal Replacement Therapy

Heparin Anticoagulation Systemic anticoagulation Requires monitoring of patient clotting

times

Page 23: Anticoagulation in Continuous Renal Replacement Therapy

Heparin Protocol Continuous infusion of 10-20

units/kg/hour Infused prefilter Loading dose may be needed Monitor postfilter activated clotting time

(ACT) Titrate heparin infusion to maintain ACT range of 180-220 seconds

Page 24: Anticoagulation in Continuous Renal Replacement Therapy

Potential Complications of Heparin Patient bleeding Heparin induced thrombocytopenia (HIT)

Page 25: Anticoagulation in Continuous Renal Replacement Therapy

Citrate and Low Dose Heparin Anticoagulation Continuous prefilter infusion of citrate and heparin Maintain citrate per protocol Heparin infusion of 5 units/kg/hour

Page 26: Anticoagulation in Continuous Renal Replacement Therapy

No Anticoagulation Typically results in short filter life

Page 27: Anticoagulation in Continuous Renal Replacement Therapy

Conclusions:  Wide range of practice exists.  Despite all best measures filters last

from hours to days.  Individual circumstances of the patient

dictate the anticoagulation regimen that is best for the patient.